Alere HIV Diagnostic Care; Solutions to Fast Track

Slides:



Advertisements
Similar presentations
Dr. Kate Templeton SPAIIN –Stirling Overview HIV Infection Tests used in diagnostic labs How to access them Challenges HIV prevention Non –conformity.
Advertisements

Integrating Rapid HIV Testing in Emergency Care Improves HIV Detection Evan M. Cadoff, MD Robert Wood Johnson Medical School New Brunswick, NJ
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
Opt-Out HIV Testing in the Denver STD Clinic Kees Rietmeijer, MD, PhD Denver Public Health Department American Society for Microbiology 107 th General.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Alere TM HIV Combo Yuko Tamanoue, Product Development Department.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Factors associated with acute HIV infection diagnosis in MSM ANRS-Opportunity study Karen.
ICTC Team Training 1 ICTC: Roles, Referrals and Linkages.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
LINKAGE OF IDENTIFIED CASES TO HEALTH FACILITIES SERVICE PROVISION TO KEY POPULATIONS KABUSUNZU HC.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Division of HIV/AIDS Prevention CDC-RFA-PS
 HIV and AIDS prevalence in the Middle East and North Africa is around 0.2% ( %) with between 230,000 and 1.4 million people infected.  Among.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Case 8 38 year-old man from Sub-Saharan Africa Came to UK in 2001 Living in London First wife died 10 years ago of TB Remarried for 7 years, wife currently.
Washington D.C., USA, July 2012www.aids2012.org bcn checkpoint H I V-A I D S ▪ S T I ▪ S E X U A L I T Y ▪ M E N ▪ H E A L T H How a Community-Based.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
BioPlex 2200 HIV Ag-Ab Assay
Commentary Thailand national guidelines for implementing HIV prevention among men who have sex with men and transgender populations As of March 2013 Frits.
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
#IAS2017 Increasing HIV test uptake & case finding through assisted HIV partner notification 25 July, 2017 Shona Dalal Department of.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Integrating Diagnostic Services at Point of Care
HIV self-testing: feasibility and acceptability of a large scale national service Cary James Head of Health Improvement Programmes Terrence Higgins Trust,
Use of POC technologies for
Introduction to Cascades
TITLE Differentiated Care for People who inject Drugs, Men who have sex with men, Sex workers, Transgender people, Prisoners and other people living in.
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Differentiated Service Delivery: Innovating for Impact
Prevalence of HIV infection among blood donors at the National Blood Transfusion Centre in Bangui, Central African Republic Claudine Bekondi1a, Pulchérie.
Singapore Last updated: November 2016.
Community Based Service Delivery Model
Rodney VanDerwarker1, Kenneth H. Mayer, MD1,2, Stephen L. Boswell, MD1
Senior Director, Health International Programs Group
California Clinical Laboratory Association
Global HIV Diagnosis Market to Witness 10.6% CAGR during 2017 – 2023.
Opportunity Analysis and Industry Forecast, HIV Diagnosis MarketHIV Diagnosis Market Top Key Players, Trends, Share to 2023tein Market.
Testing and linking different key population groups in Ukraine
HIV prevention in a Fast Track City
Acute HIV Infection and PrEP: Opportunities and challenges
Elements of the Care Continuum
Nittaya Phanuphak, MD, PhD 
Edward Mbizo Sibanda, (MSc) Right to Care
Dr Van Nguyen World Health Organization AIDS July 2018
The Politics of PrEP The French Experience
Key population-led health services (KP-LHS) critical to PrEP introduction among men who have sex with men (MSM) and transgender women (TGW) in Thailand.
An Update from CROI and the Changing Landscape of HIV in NZ
Sarah E. Rutstein, MD, PhD University of North Carolina at Chapel Hill
Amsterdam, Netherlands 26 July 2018
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Division of Global HIV & TB
Hidden Opportunities - What Will It Take to Reach in Eastern Europe?
Needs Assessment Slides for Module 4
A review of research, policy and programming
Summary Sheet Figures and Maps
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
HIV in Minnesota: Challenges and Opportunities
Summary Sheet Figures and Maps
TRACE INITIATIVE: Overview
Illustrative Cluster Detection and Response Strategy
Dismas Gashobotse, MD FHI 360/LINKAGES, Burundi
HIV Testing- What’s Your Routine?
Reshmie Ramautarsing, M.D., Ph.D.
Managing Hepatitis C in Vermont
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Alere HIV Diagnostic Care; Solutions to Fast Track 90-90-90 Value of Earlier Case Findings using Alere™ HIV Combo in a Community Setting Michael Meulbroek Projecte dels NOMS-Hispanosida Alere HIV Diagnostic Care; Solutions to Fast Track 90-90-90 Paris, 25 July 2017

Introduction 2007 UNAIDS Global Campaign “ Know Your Epidemic, Know Your Response”.

Europe 2006 - 2015

The HIV epidemic is concentrated in the cities UNAIDS gap report 2015

Opening of BCN Checkpoint BCN Checkpoint opened in January 2006 A community center for gay men, other men who have sex with men and transgender women Situated in the middle of Barcelona’s gay area Service is free, anonymous and confidential Peer counselors: all are gay and most are HIV+ BCN Checkpoint introduced the use of HIV rapid tests in community centers in Europe in 2006

Introduction of HIV Rapid Test in a non-clinical setting (2006) To reduce high number of persons that doesn’t come back for the result of an HIV test Acceptability test 93.2% important to obtain result in 30 minutes 97.7% positive opinion to offer rapid test in a community center Specific training for counselors Informed consent: Counselor is a peer Positive result needs confirmation

Results of the introduction of HIV Rapid Testing in non-clinical settings

Number of tests and clients in BCN Checkpoint (2006 - 2016) 7,737 5,542 3,837 3,198

Positive results and rate (2006 - 2016) 172 146 132 37

Impact of BCN Checkpoint Source: Actualizació a 06/10/2016. Vigilància epidemiològica de la infecció pel VIH i la SIDA a Catalunya. Ceeiscat. Departament de Salut. Generalitat de Catalunya

Linkage to Care

Need to detect HIV infections earlier New HIV Infections

Early phases of HIV infection

Transmission risk acute infections Blood viral load in acute HIV (n=171) Average fitted curve, with 95% confidence intervals log 10 HIV RNA 8 7 6 5 4 3 2 1 8-10 fold increase risk from peak to day 54 300 200 100 Days from Infection Peak: day 23 Pilcher, et al JID 2004

Challenges to find earlier HIV infections Recommend and promote regular testing in key populations

Campaign for more frequent testing (2014)

Campaign for more frequent testing (2015) Gay men do it often!

Campaign for more frequent testing (2016)

Challenges to find earlier HIV infections Recommend and promote regular testing in key populations Use P24 antigen in usual screening in key populations Alere™ HIV Combo

Detection of P24 antigen before antibodies Acute Seroconversion→Established Das G et al. BMJ 2010;341:bmj.c4583

Test, detect and start treatment Kroon EDMB et al. Journal of the International AIDS Society 2017, 20:21708 http://dx.doi.org/10.7448/IAS.20.1.21708 Published 28 June 2017

Detection of P24 antigen Introduction Alere™ HIV Combo: 25 March 2016 Period: 25 March 2016 – 31 December 2016 Total tests performed: 5,800 Total persons tested: 4,485 Total reactive tests: 113   antibodies P24 and antibodies P24 Total Total reactive tests 106 3 4 113 False positive results 5 1 6 Confirmed positive results 101 107 + 2.9% + 5.9%

Time to start treatment Added value detection of P24 antigen Cases Age Marker Time to hospital Time to start treatment VL (millions) CD4 Nº 1 35 P24 1 day same day > 10 257 Nº 2 46 332 Nº 3 60 2 days 4.60 385 Nº 4 45 P24 and antibodies 16 days 0.57 301 Nº 5 22 12 days 3 days 0.27 144 Nº 6 28 5 days 0.24 238

Results Resource: results BCN Checkpoint 2012-2016

Results Early Detection + Fast Linkage to Care + Treatment Source: Agència de Salur Pública. La Salut a Barcelona 2015. Published: December 2016

Detección infecciones agudas en BCN Checkpoint Late diagnostics Detección infecciones agudas en BCN Checkpoint Alere Pima™ Point-of-Care CD4 test

Summary In Europe the HIV epidemic concentrates mostly in MSM and other key populations and in urban areas. MSM need a specific action plan that includes targeting testing and linkage to care, increase testing frequency and screening for acute infections. Community centers has shown to be effective with the use of POCT in key populations. However, if we want to reduce the gap in the first step of the continuum of care HIV infections should be found in the earliest phases in order to reduce the ongoing transmission chain. The use of Alere™ HIV Combo in BCN Checkpoint permits a general screening to all clients for early HIV infections. Results from 2016 show that at least 2.9% more cases were found where standard antibody tests would have been a missed opportunity. Moreover, cases with only P24 antigen had a significant higher viral load, hence detection in this phase of infection saves 8-10 times more onwards infections and is an important tool for reaching the 90-90-90 goals.

Acknowledgements